Adrienne Sallets
Université catholique de Louvain
7 Papers
3 Citations
Adrienne Sallets is an academic researcher from Université catholique de Louvain. The author has contributed to research in topics: Medicine & Reporter gene. The author has an hindex of 3, co-authored 4 publications. Previous affiliations of Adrienne Sallets include Catholic University of Leuven.
Chat about Author
Papers
Transient production of artemisinin in Nicotiana benthamiana is boosted by a specific lipid transfer protein from A. annua.
Bo Wang,Arman Beyraghdar Kashkooli,Adrienne Sallets,Hieng-Ming Ting,Norbert C.A. de Ruijter,Linda Olofsson,Peter E. Brodelius,Mathieu Pottier,Marc Boutry,Harro J. Bouwmeester,Alexander R. van der Krol +10 more
TL;DR: It is demonstrated that Lipid Transfer Protein 3 (AaLTP3) and the transporter Pleiotropic Drug Resistance 2 (A aPDR2) from A. annua enhance accumulation of (DH)AA in the apoplast of N. benthamiana leaves.
99
Isolation of heat shock-induced Nicotiana tabacum transcription promoters and their potential as a tool for plant research and biotechnology
Catherine Navarre,Adrienne Sallets,Emilie Gauthy,Marie Maîtrejean,Bertrand Magy,Joseph Nader,Cédric Pety de Thozée,Jérôme Crouzet,Henri Batoko,Marc Boutry +9 more
TL;DR: Data show that the HSP promoters isolated are useful for high heat-induced expression in N. tabacum BY-2 cells.
33
Lysine-Derived Charge-Altering Releasable Transporters: Targeted Delivery of mRNA and siRNA to the Lungs.
Timothy R. Blake,Ole Audun Werner Haabeth,Adrienne Sallets,Rebecca L. McClellan,Trevor J. Del Castillo,Jose G. Vilches-Moure,Wilson Ho,Paul A. Wender,Ronald Levy,Robert M. Waymouth +9 more
TL;DR: In this paper , the authors reported a new lysine-derived CART-mRNA complex (K-CART/mRNA) that, without additives or targeting ligands, shows selective protein expression in the lungs (mouse, >90%) following systemic IV administration.
15
Stable and transient transformation of Artemisia annua suspension cells
TL;DR: An A. annua cell line, AaSA, derived from leaf tissues is established and transient expression of GUS was observed after 4–6 days of co-cultivation, opening the way for metabolic engineering of A.annua cells.
3
1084 NTX-0250, a multimodal mRNA-based immunotherapy, eradicates large established tumors in a stringent mouse model of HPV16-driven cancer
Ole Audun Werner Haabeth,Diane M. DaSilva,Colin J. McKinlay,Weiqun Liu,Edward E. Lemmens,C. Rae,Adrienne Sallets,Daniel O. Frimannsson,Sangeeta Nath,Nicole Peck,Ou Li,Nicole C. Fay,Ruben Prins,Meredith L. Leong,W. Martin Kast,Samuel Deutsch +15 more
- 01 Nov 2022
TL;DR: NTX-0250 as mentioned in this paper is a nanoparticle-formulated, multi-component mRNA drug that co-delivers a novel HPV16 antigen design with two potent immunomodulators.